Overview
My work focuses on analyzing and improving the quality of clinical and surgical care in the field of retinal diseases. I am passionate about improving the quality of life for my patients by preserving and restoring their vision, but am also very interested in treating people on a larger scale. One way of doing so is by evaluating treatment outcomes across populations, and then identifying factors that contribute to excellent outcomes. I also specialize in the medical and surgical management of complex conditions including retinal detachment, epiretinal membrane, floaters, macular degeneration, and diabetic retinopathy.
Dr. Weng is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.
Her clinical research consists of co-authoring 153 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 10 articles in the study of Retinitis Pigmentosa.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1977 Butler Blvd, Ste E3.100 MS BCM 633, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Utmb Faculty Group Practice
Fredericus Van Kuijk is an Ophthalmologist in Galveston, Texas. Dr. Van Kuijk is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, Cone Rod Dystrophy Amelogenesis Imperfecta, and Usher Syndrome Type 2A. Dr. Van Kuijk is currently accepting new patients.
Baylor College Of Medicine - Ophthalmology
Dr. Stout has been the Sid W. Richardson Professor and Margarett Root Brown Chair of the Department of Ophthalmology, and Director of the Cullen Eye Institute at Baylor College of Medicine since 2013. Prior to that he served as Professor in the Departments of Ophthalmology and Molecular Genetics, as well as Vice President for Commercialization Strategies at Oregon Health & Science University in Portland, Oregon. He has directed the Clayton Gene Therapy Laboratories since 1995. Dr. Stout brings experience from both the research and clinical sides of medicine. His research interests include human gene and cell-based therapy for proliferative and inherited ocular disease, retinal disease genotype-phenotype correlation and ocular disease gene mapping and discovery. Dr. Stout is rated as an Advanced provider by MediFind in the treatment of Retinitis Pigmentosa. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), Cone Rod Dystrophy Amelogenesis Imperfecta, and Vitrectomy.
Hea Clinic PA
Lindsey Harris is an Ophthalmologist in Houston, Texas. Dr. Harris is rated as a Distinguished provider by MediFind in the treatment of Retinitis Pigmentosa. Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Choroid Plexus Carcinoma. Dr. Harris is currently accepting new patients in some locations.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Diabetic RetinopathyDr. Weng isElite. Learn about Diabetic Retinopathy.
- Distinguished
- Age-Related Macular Degeneration (ARMD)Dr. Weng isDistinguished. Learn about Age-Related Macular Degeneration (ARMD).
- Diabetic Macular Edema (DME)Dr. Weng isDistinguished. Learn about Diabetic Macular Edema (DME).
- Late-Onset Retinal DegenerationDr. Weng isDistinguished. Learn about Late-Onset Retinal Degeneration.
- Retinal DetachmentDr. Weng isDistinguished. Learn about Retinal Detachment.
- Retinopathy Pigmentary Mental Retardation
- Usher Syndrome Type 2ADr. Weng isDistinguished. Learn about Usher Syndrome Type 2A.
- Advanced
- Coats DiseaseDr. Weng isAdvanced. Learn about Coats Disease.
- EndophthalmitisDr. Weng isAdvanced. Learn about Endophthalmitis.
- Familial Exudative Vitreoretinopathy
- Geographic AtrophyDr. Weng isAdvanced. Learn about Geographic Atrophy.
- NeuroretinitisDr. Weng isAdvanced. Learn about Neuroretinitis.
- Retinal Vasculopathy with Cerebral Leukodystrophy
- Experienced
- Aplasia Cutis CongenitaDr. Weng isExperienced. Learn about Aplasia Cutis Congenita.
- Arteriovenous MalformationDr. Weng isExperienced. Learn about Arteriovenous Malformation.
- Birdshot ChorioretinopathyDr. Weng isExperienced. Learn about Birdshot Chorioretinopathy.
- CataractDr. Weng isExperienced. Learn about Cataract.
- Cataract RemovalDr. Weng isExperienced. Learn about Cataract Removal.
- Central Serous ChorioretinopathyDr. Weng isExperienced. Learn about Central Serous Chorioretinopathy.